<DOC>
	<DOCNO>NCT02719522</DOCNO>
	<brief_summary>This prospective , single-arm , multi-center post-market observational study assess performance Pipeline™ Flex Embolization Device Shield Technology™ subject undergoing treatment intracranial aneurysms large real-world , post-market setting .</brief_summary>
	<brief_title>Pipeline Flex With SHield Technology Embolization - An International MulticEnter ObservationaL Post Market StuDy</brief_title>
	<detailed_description>Eligible subject treat Pipeline™ Flex Embolization Device Shield Technology™ . Subjects undergo standard care follow-up visit . Data generate per standard care collect 1 year beyond index procedure .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Subject provide write Data Release Form ( DRF ) inform consent use Institutional Review Board ( IRB ) / Ethic Committee ( EC ) approve consent form agree comply protocol requirement . At least 18 year age . Subject already select flow diversion therapy appropriate treatment . Major surgery include endovascular procedure within past 30 day . Subject anatomy appropriate endovascular treatment . Stent place parent artery target IA location . Any known contraindication treatment Pipeline™ Flex Embolization Device Shield Technology™ per Instructions Use . The investigator determine health subject validity study outcome ( e.g. , high risk neurologic event , condition may increase chance stroke , worsen clinical condition last 30 day ) may compromise subject 's enrollment . Pregnant breastfeed woman woman wish become pregnant length study participation . Subject currently enrol plan participate potentially confound drug device trial course study . Legal incapacity evidence subject understand purpose risk study inability comply fully study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>